OcellO
Business Services · 11-50 Employees
View Company Info for Free
Overview
Phone Number
+31 713322871Website
www.ocello.nlRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About OcellO
OcellO is a leading provider of compound testing services using advanced organotypic human tissue models of cancer, inflammation, and polycystic kidney disease. Automated 3D cell culture technology is combined with high content 3D imaging and analysis in a robust platform that provides scalability without compromising biological complexity. Cancer drug discovery services utilize organoids, PDX- derived tumoroids and patient tumor-derived models representing most solid tumor types and incorporating different components of the immune system.Explore more
OcellO Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is OcellO your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once OcellO has new funding data
Website visits: Recent activity has been detected on your website
Click to see if OcellO had a recent Job posting/layoffs
OcellO, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on OcellO recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if OcellO has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when OcellO launches new products
Congratulate Masked Content for being promoted to Masked Content at OcellO
Check out if OcellO is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined OcellO as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
OcellO is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
OcellO is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about OcellO.
OcellO Tech Stack
A closer look at the technologies used by OcellO
OcellO News & Media
CrownBio Acquires OcellO B.V. to Expand Its Preclinical In Vitro Drug Development Service Offerings
SAN DIEGO--(BUSINESS WIRE)--CrownBio acquires OcellO to expand preclinical in vitro drug development services, adding HCI & advanced tumor organoid analytics to 3D IO drug assaysOcellO announces two year agreement with Merus to provide in vitro research services for MCLA-158 and other undisclosed Biclonics® programs
LEIDEN, the Netherlands, March 28, 2019 (GLOBE NEWSWIRE) -- OcellO B.V., a Contract Research Organisation offering 3D cell based assay services for drug discovery to the pharmaceutical industry, today announced that it entered an agreement to provide in vitro research services to Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, for Merus’ MCLA-158 Biclonics® program and other undisclosed Biclonics® discovery programs.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding OcellO
Sign Up For FreeTo access detailed company insights
OcellO is a leading provider of compound testing services using advanced organotypic human tissue models of cancer, inflammation, and polycystic kidney disease. Automated 3D cell culture technology is combined with high content 3D imaging and analysis in a robust platform that provides scalability without compromising biological complexity. Cancer... Read More
